DelSiTech’s CEO Lasse Leino is pleased to announce that Dr. Cora Griffin has been promoted to the position of Director, Head of Business Development. At the same time, she was appointed as a member of the Company Management Team. Dr. Griffin held the role of Business Development Manager at DelSiTech since April 2014 and has watched the company grow with its evolving proprietary technology and large therapeutic area focus. Prior to DelSiTech, Dr. Griffin held business development positions at Q Chip Ltd, a polymer-based drug delivery company and Arrow Therapeutics, an antiviral drug development company owned by AstraZeneca.